DCF — CARONDELET ST. MARYS HOSPITAL
Enterprise Value: $-319.1M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-319.1M
Enterprise Value
$-100.0M
PV of Cash Flows
$-219.1M
PV of Terminal Value
$-352.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $172.2M | $-20.4M | -12.0% | $-27.7M | $-25.2M |
| Year 2 | $177.4M | $-19.2M | -11.0% | $-26.7M | $-22.1M |
| Year 3 | $182.7M | $-18.0M | -10.0% | $-25.7M | $-19.3M |
| Year 4 | $188.2M | $-17.6M | -9.0% | $-25.5M | $-17.4M |
| Year 5 | $193.8M | $-17.6M | -9.0% | $-25.8M | $-16.0M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-319.1M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$167.2M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.12336605496269977
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5